A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.

Last updated: September 16, 2024
Sponsor: Equipmed USA LLC
Overall Status: Active - Not Recruiting

Phase

2/3

Condition

Scalp Disorders

Rash

Acne

Treatment

Dermapen 4™

Clinical Study ID

NCT06602284
SKIN/EMAC/2024-01
  • Ages 18-45
  • Female
  • Accepts Healthy Volunteers

Study Summary

This study is conducted to check how well the Dermapen 4™ microneedling device works with MG-CLR serum for treating acne over 12 weeks.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Female subjects aged between 18-45 years (both ages inclusive)

  2. Fitzpatrick skin phototype I to VI.

  3. Subjects having IGA score of 2 and 3.

  4. Subjects who have not received any kind of treatment for acne 1 month before thestart of the study.

  5. Subject free of excessive hair, cuts, abrasions, fissures, wounds, lacerations, orany other skin conditions on the face.

  6. Subjects who agree not to use any other product/treatment/home remedy/ except theprovided products on their face during the study period

Exclusion

Exclusion Criteria:

  1. Subjects with known skin condition that may impact the assessment.

  2. Subjects with active Herpes labialis infection.

  3. Subjects known to have bleeding and clotting disorders (self-declared).

  4. Subjects known to have connective tissue disorders.

  5. Subjects with any other signs of significant local irritation or skin disease.

  6. Subjects currently taking any medication, which the investigator believes mayinfluence the interpretation of the data.

Study Design

Total Participants: 10
Treatment Group(s): 1
Primary Treatment: Dermapen 4™
Phase: 2/3
Study Start date:
October 01, 2024
Estimated Completion Date:
March 31, 2025

Connect with a study center

  • Skin Wellness Dermatology

    Birmingham, Alabama 35209
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.